DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ford HE, Marshall A, Bridgewater JA, Janowitz T, Coxon FY, Wadsley J. et al.
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): An open-label, phase 3 randomised controlled trial.
Lancet Oncol 2014;
15: 78-86
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.